Found: 18
Select item for more details and to access through your institution.
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40022-5
- By:
- Publication type:
- Article
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37537-2
- By:
- Publication type:
- Article
The Nephroprotective Effect of Zizyphus lotus L. (Desf.) Fruits in a Gentamicin-Induced Acute Kidney Injury Model in Rats: A Biochemical and Histopathological Investigation.
- Published in:
- Molecules, 2021, v. 26, n. 16, p. 4806, doi. 10.3390/molecules26164806
- By:
- Publication type:
- Article
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
- By:
- Publication type:
- Article
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article
mTOR Repression in Response to Amino Acid Starvation Promotes ECM Degradation Through MT1‐MMP Endocytosis Arrest.
- Published in:
- Advanced Science, 2021, v. 8, n. 17, p. 1, doi. 10.1002/advs.202101614
- By:
- Publication type:
- Article
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01158-3
- By:
- Publication type:
- Article
HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2017, doi. 10.1002/1878-0261.13412
- By:
- Publication type:
- Article
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17697-1
- By:
- Publication type:
- Article
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
- Published in:
- 2021
- By:
- Publication type:
- journal article
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03296-x
- By:
- Publication type:
- Article
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-178
- By:
- Publication type:
- Article
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-178
- By:
- Publication type:
- Article
Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1 -Mutated Human Chordoma Xenograft.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1486, doi. 10.3390/cancers14061486
- By:
- Publication type:
- Article
The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
- Published in:
- Journal of Neurosurgery, 2023, v. 139, n. 5, p. 1270, doi. 10.3171/2023.1.JNS222180
- By:
- Publication type:
- Article
A large collection of integrated genomically characterized patient‐derived xenografts highlighting the heterogeneity of triple‐negative breast cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1902, doi. 10.1002/ijc.32266
- By:
- Publication type:
- Article